Company intelligence / Profile preview

CardioNavix

United States

Ownership: Private
Development stage: Other

Overview

CardioNavix, a business line of CDL Nuclear Technologies, commercially provides patented, on‑demand mobile rubidium‑82 generator and infusion systems to healthcare facilities so they can perform cardiac PET or PET/CT imaging on scheduled days using existing scanners, with CDL handling delivery, setup, removal, licensing support, and staff training.[2][3][5]

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Medical Imaging

Partnerships

Bracco Diagnostics (CardioGen‑82 rubidium‑82 infusion system partnership)[7]

Beyond the preview

Go deeper on CardioNavix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CardioNavix.

Explore the full profile